Atlas Trials

Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)

Clinical trial NCT00606580 · COMPLETED

Trial details

NCT number
NCT00606580
Sponsor
U.S. Army Medical Research and Development Command
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cutaneous Leishmaniasis
Start date
2008-01-01
Primary completion
2011-07-01
Enrollment
375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.